INTERNATIONAL PATENT: VERTEX PHARMACEUTICALS INCORPORATED FILES APPLICATION FOR "COMBINATION OF VANZACAFTOR, TEZACAFTOR, DEUTIVACAFTOR FOR USE IN TREATING CYSTIC FIBROSIS"

GENEVA, Aug. 13 -- VERTEX PHARMACEUTICALS INCORPORATED (50 Northern AvenueBoston, Massachusetts 02210) filed a patent application (PCT/US2025/014303) for "COMBINATION OF VANZACAFTOR, TEZACAFTOR, DEUTIVACAFTOR FOR USE IN TREATING CYSTIC FIBROSIS" on Feb 03, 2025. With publication no. WO/2025/166342, the details related to the patent application was published on Aug 07, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): BOREK, Bartlomiej (50 Northern AvenueBoston, Massachusetts 02210), BOZIC, Carmen (50 Northern AvenueBoston, Massachusetts 02210), CHEN, Weichao George (50 Northern AvenueBoston, M...